Midway through trading Thursday, the Dow traded down 0.08% to 34,768.64 while the NASDAQ rose 0.10% to 14,646.39. The S&P also fell, dropping 0.02% to 4,357.70.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 34,229,800 cases with around 609,870 deaths. India confirmed a total of at least 31,257,720 cases and 418,980 deaths, while Brazil reported over 19,473,950 COVID-19 cases with 545,600 deaths. In total, there were at least 192,054,100 cases of COVID-19 worldwide with more than 4,128,050 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Information technology shares climbed 0.6% on Thursday. Meanwhile, top gainers in the sector included ACM Research, Inc. ACMR 3.95%, up 4%, and Veritone, Inc. VERI 4.33%, up 4%.

In trading on Thursday, energy shares fell 1.2%.

Top Headline

AT&T Inc. T 0.29% reported better-than-expected results for its second quarter.

AT&T reported quarterly adjusted earnings of $0.89 per share, beating analysts’ estimates of $0.79 per share. The company’s revenue came in at $44.05 billion, versus expectations of $42.64 billion.

AT&T said it expects FY21 sales growth in the 2-3% range and also projects adjusted EPS to grow in the mid to mid-single digits.

Equities Trading UP

NRx Pharmaceuticals, Inc. NRXP 46.09% shares shot up 45% to $14.69 as the company said it has validated the first commercial formulation of Zyesami for intravenous use, allowing for high volume manufacturing, with an anticipated one year or greater stability under appropriate storage conditions.

Shares of Summit Wireless Technologies, Inc. WISA 32.68% got a boost, shooting 31% to $5.34 after the company highlighted the launch of its Amazon storefront.

ImmunoPrecise Antibodies Ltd. IPA 169.59% shares were also up, gaining 143% to $13.47 after the company announced new results from its TATX-03 PolyTope Therapy, demonstrating potent pseudovirus neutralizing activity against the SARS-CoV-2 Delta (B.1.617.2) variant.

Equities Trading DOWN

Seres Therapeutics, Inc. MCRB 55.6% shares tumbled 55% to $9.40 after the company announced topline results from the Phase 2b ECO-RESET study evaluating SER-287 in patients with mild-to-moderate ulcerative colitis (UC). The study did not meet its primary endpoint of improving clinical remission rates compared to placebo.

Shares of TRACON Pharmaceuticals, Inc. TCON 23.83% were down 24% to $3.7450 after the company announced it increased a previously announced bought deal offering of common stock to $15 million.

Jupiter Wellness, Inc. JUPW 24.38% was down, falling 24% to $2.12 after the company announced pricing of a $32.5 million underwritten public offering of common stock and warrants.

Commodities

In commodity news, oil traded up 1.5% to $71.40, while gold traded up 0.2% to $1,806.60.

Silver traded up 0.6% Thursday to $25.405 while copper rose 1.3% to $4.3275.

Euro zone

European shares were mostly higher today. The eurozone’s STOXX 600 rose 0.56%, the Spanish Ibex Index rose 0.64% and the German DAX 30 gained 0.35%. Meanwhile, the London’s FTSE 100 fell 0.56%, French CAC 40 surged 0.17% and Italy’s FTSE MIB climbed 0.53%.

The European Central Bank announced plans to keep interest rates and asset purchases unchanged. The manufacturing climate indicator in France climbed to 110 in July from a revised reading of 108 in the prior month. The CBI's quarterly gauge of manufacturing optimism for the UK declined to 27 in the third quarter compared to 38 in the prior three-month period.

Economics

US initial jobless claims rose to 419,000 in the latest week, versus a revised reading of 368,000 in the previous week.

The Chicago Fed National Activity Index fell to 0.09 in June from a revised reading of 0.26 in May.

Existing home sales rose 1.4% to 5.86 million in June.

The index of leading economic indicators rose 0.7% for June.

The Kansas City Fed's manufacturing production index surged to a record high of 41 in July versus 30 in the prior month.

Benzinga does not provide investment advice. All rights reserved.

Recommended Content


Recommended Content

Editors’ Picks

AUD/USD: The hunt for the 0.7000 hurdle

AUD/USD: The hunt for the 0.7000 hurdle

AUD/USD quickly left behind Wednesday’s strong pullback and rose markedly past the 0.6900 barrier on Thursday, boosted by news of fresh stimulus in China as well as renewed weakness in the US Dollar.

AUD/USD News
EUR/USD refocuses its attention to 1.1200 and above

EUR/USD refocuses its attention to 1.1200 and above

Rising appetite for the risk-associated assets, the offered stance in the Greenback and Chinese stimulus all contributed to the resurgence of the upside momentum in EUR/USD, which managed to retest the 1.1190 zone on Thursday.

EUR/USD News
Gold holding at higher ground at around $2,670

Gold holding at higher ground at around $2,670

Gold breaks to new high of $2,673 on Thursday. Falling interest rates globally, intensifying geopolitical conflicts and heightened Fed easing bets are the main factors. 

Gold News
Bitcoin displays bullish signals amid supportive macroeconomic developments and growing institutional demand

Bitcoin displays bullish signals amid supportive macroeconomic developments and growing institutional demand

Bitcoin (BTC) trades slightly up, around $64,000 on Thursday, following a rejection from the upper consolidation level of $64,700 the previous day. BTC’s price has been consolidating between $62,000 and $64,700 for the past week.

Read more
RBA widely expected to keep key interest rate unchanged amid persisting price pressures

RBA widely expected to keep key interest rate unchanged amid persisting price pressures

The Reserve Bank of Australia is likely to continue bucking the trend adopted by major central banks of the dovish policy pivot, opting to maintain the policy for the seventh consecutive meeting on Tuesday.

Read more
Five best Forex brokers in 2024

Five best Forex brokers in 2024

VERIFIED Choosing the best Forex broker in 2024 requires careful consideration of certain essential factors. With the wide array of options available, it is crucial to find a broker that aligns with your trading style, experience level, and financial goals. 

Read More

Majors

Cryptocurrencies

Signatures